Akoya Biosciences, Inc.
AKYA
$1.10
-$0.06-5.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.39% | -2.38% | -20.63% | -26.55% | -25.92% |
| Total Receivables | -14.78% | 7.77% | -22.76% | 22.87% | -20.72% |
| Inventory | -6.04% | -3.53% | 1.68% | 7.86% | 28.59% |
| Prepaid Expenses | 24.90% | 9.91% | 0.99% | -22.54% | -0.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.71% | -0.17% | -14.13% | -12.10% | -16.39% |
|
|
|||||
| Total Current Assets | -13.71% | -0.17% | -14.13% | -12.10% | -16.39% |
| Net Property, Plant & Equipment | -6.91% | -7.09% | -3.45% | -8.87% | -23.12% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.90% | -4.67% | -4.47% | -4.27% | -4.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.11% | 11.92% | 9.37% | -3.03% | -7.51% |
| Total Assets | -9.88% | -3.82% | -9.58% | -7.11% | -14.20% |
|
|
|||||
| Total Accounts Payable | 17.49% | -0.01% | -10.48% | -8.95% | -8.74% |
| Total Accrued Expenses | 0.89% | 25.60% | -35.22% | 46.26% | -31.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2,327.69% | -10.72% | 10.69% | -1.48% | -2.20% |
| Total Finance Division Other Current Liabilities | 6.88% | 1.29% | -4.30% | -23.03% | 23.05% |
| Total Other Current Liabilities | 6.88% | 1.29% | -4.30% | -23.03% | 23.05% |
| Total Current Liabilities | 267.08% | 5.18% | -14.49% | -1.37% | -6.09% |
|
|
|||||
| Total Current Liabilities | 267.08% | 5.18% | -14.49% | -1.37% | -6.09% |
| Long-Term Debt | -- | 0.37% | 0.29% | 0.28% | 0.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.08% | -12.34% | -6.18% | -10.32% | -9.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -9.42% | -0.03% | -3.75% | 5.19% | -21.99% |
| Total Liabilities | 0.96% | 0.92% | -4.24% | -0.44% | -3.61% |
|
|
|||||
| Common Stock & APIC | 0.74% | 0.74% | 0.66% | 0.93% | 0.86% |
| Retained Earnings | -5.48% | -2.96% | -3.95% | -5.19% | -10.21% |
| Treasury Stock & Other | -114.29% | -12.50% | 166.67% | 25.00% | -- |
| Total Common Equity | -177.54% | -44.29% | -38.73% | -32.01% | -39.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -177.54% | -44.29% | -38.73% | -32.01% | -39.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -177.54% | -44.29% | -38.73% | -32.01% | -39.14% |
|
|
|||||